WellSpan-THRIVE Cancer QOL Study

Part of paid clinical trials in Chambersburg, Pennsylvania.

Sponsor
WellSpan Health
Study ID
NCT07433660
Status
Recruiting

Conditions

  • Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative
  • Cancer (Advanced Stage)
  • Cancer (Solid Tumors)
  • Cancer (With or Without Metastasis)
  • Cancer - Ovarian
  • Cancer Abdomen

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences. This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.

Key Dates

Start date
Feb 28, 2026
Status verified
Feb 2026
Primary completion
Feb 28, 2031
Completion
Dec 31, 2031

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Patients Diagnosed with primary cancer in past 6 months
    Patients Diagnosed with primary cancer in past 6 months will be divided into Race, ethnicity and gender and will be looked for differences in quality of life based on these subsets.

Primary Outcome Measure

Quality of Life Differences based on Race or Ethnicity or Gender [ Time Frame: Baseline, 6-12-18-24 months ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
WellSpan Medical Oncology & HematologyChambersburgPennsylvania17201
Tara Reed, RN, OCN
717-217-6017
WellSpan Ephrata Cancer CenterEphrataPennsylvania17522
Karen Comerford, RN, OCN
717- 721-4838
WellSpan Adams Cancer CenterGettysburgPennsylvania17325
Erin Hill, RN, OCN
717-339-2638
WellSpan Sechler Family Cancer CenterLebanonPennsylvania17042
Lauren Adams, RN
717-639-3924
WellSpan York Cancer CenterYorkPennsylvania17403
Joan K Moore, MSN, RN, OCN, CCRP
717-741-8124
Rahul Kashyap, MBBS, MBA, FCCM
717-851-4611

Find similar trials in Chambersburg, PA

Related Studies